ERBB2 and breast cancer: To evaluate the possibility to prevent the age-dependent appearance of mammary tumours in HER-2/neu transgenic mice, we elaborated a protocol of immunization performed in young age that could be effective until very old ages, overcoming the defects linked to the immunosenescence.